BioStrand is an innovative brand at the forefront of revolutionizing drug discovery through their AI-powered biotherapeutic SaaS platform. With a mission to uncover the unknown and transform the discovery process, BioStrand is dedicated to enhancing human health through cutting-edge technology. Their patented LENS ai ™ Integrated Intelligence Technology, powered by HYFTs ®, seamlessly integrates massive data from diverse sources, providing comprehensive insights to accelerate drug discovery while maintaining scientific excellence.

BioStrand offers a unified and integrated data view through their cloud-based platform, enabling rapid insights with security, traceability, and collaboration. With advanced analytics tools utilizing proprietary algorithms and HYFTs, users can effortlessly organize and access vast and diverse data sets. By combining in silico analysis supported by in vitro and in vivo workflows, BioStrand's technology allows for efficient evaluation of drug interactions and prioritization of lead candidates based on predicted efficacy, toxicity, and functional properties.

Backed by a team of AI experts and a globally ranked CRO, BioStrand is leading the way in precision medicine and offering a market-changing strategic approach in antibody discovery. Through their integrated power of multi-omics data solutions and the application of their LENS ai technology, BioStrand is breaking barriers and transforming therapeutic discovery. Join BioStrand in their AI revolution and experience the future of drug discovery